🇺🇸 Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) in United States

Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) (tozinameran-bnt162b2-riltozinameran-bnt162b2-omi-ba-1) regulatory status in United States.

Marketing authorisation

FDA

Status: approved

Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

🇨🇦 Canada
🇪🇺 European Union
🇬🇧 United Kingdom

Other Immunology approved in United States

Frequently asked questions

Is Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.